• Home
  • Medinfo
  • Perjeta Storage Preparation and Administration Recommendations

Perjeta and the Compatibility of In-Line Filters

This article responds to your request for information on Perjeta® (pertuzumab) and the compatibility of in-line filters.

Download article Download

Last updated March 12, 2023

Compatibility of in-line filters

While in-line filters are not required for use, Perjeta has demonstrated compatibility with the following in-line filters

  • 0.2 µm polyethersulfone (PES) in-line filter
    • 15 µm Nylon in-filter, and
      • 200 µm polyamide in-line filter.[1]
         

        No data are available for the use of cellulose in-line filters with Perjeta.[2]

        Filter compatibility study

        Compatibility of in-line filters were evaluated using an infusion solution of 420 mg of Perjeta, diluted to approximately 1.5 mg/mL in 0.9% NaCl.[1]

        References

        1. Roche Internal Technical Report. Accessed 12 July 2023.

        2. Roche Internal Communications. Accessed 12 July 2023.

        Welcome to Medically

        The Roche Science Hub

        This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

        Not a healthcare professional? Browse:

        This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

        You are Leaving Medically

        By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

        You are Leaving the Global Medically Site

        By following this link, you are being redirected to another Roche page.